Usharani Wahengbam
Trial Manager
Usharani is a trial manager for the DOLFIN study. DOLFIN is a multicentre, randomised placebo-controlled trial which aims to investigate whether a nutritional supplement improves neurodevelopment in neonates at risk for neurodevelopmental impairment.
She has several years of experience in data management and trial management for oncology, metabolism, cardiovascular and women’s health therapeutic areas from Accenture pvt Ltd, IQVIA, Oxford University Hospitals and the Oncology Department of the University of Oxford prior to joining the National Perinatal Epidemiology Unit (NPEU).
Usharani has a Master's of Microbiology from Bangalore University, India.